CAS: 1342276-76-9
1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea
CAS:1342276-76-9
Formula:
C17H16N4O2S
Purity:
99%
Color and Shape:
Solid
Molecular weight:
340.3995
Ref: IN-DA009W9U
| 5mg | 191.00 € | ||
| 25mg | 560.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
RKI1313
CAS:1342276-76-9
RKI1313 (RKI-1313) was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, …
Formula:
C17H16N4O2S
Purity:
99.06% - ≥95%
Color and Shape:
Solid
Molecular weight:
340.4
Ref: TM-T2011
| 1mg | 72.00 € | ||
| 5mg | 141.00 € | ||
| 10mg | 205.00 € | ||
| 25mg | 366.00 € | ||
| 50mg | 549.00 € | ||
| 100mg | 824.00 € | ||
| 1mL*10mM (DMSO) | 588.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Ref: 10-F940607
| 5mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
RKI-1313
CAS:1342276-76-9
RKI-1313 is an analog of RKI-1447 that is more potent as an inhibitor of ROCK1 …
Formula:
C17H16N4O2S
Purity:
Min. 95%
Molecular weight:
340.4 g/mol
Ref: 3D-SDC27676
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
